Ismail Can

9PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 29, 2026
SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling.

Imene Hamaidi, Pingyan Cheng, Soo Young Jun

|Sep 12, 2024
IL-4 drives exhaustion of CD8+ CART cells.

Carli M Stewart, Elizabeth L Siegler, R Leo Sakemura

|Oct 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei

|Jun 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.

R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox

|May 24, 2023
Hyperphosphorylated PTEN exerts oncogenic properties.

Janine H van Ree, Karthik B Jeganathan, Raul O Fierro Velasco

|Jan 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.

Reona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler

Pageof 2

Frequent Collaborators

4 joint publications

Reona Sakemura

4 joint publications

Elizabeth L Siegler

4 joint publications

Michelle J Cox

4 joint publications

Claudia Manriquez Roman